152 related articles for article (PubMed ID: 6743979)
1. Inhibition of experimental colorectal cancer by razoxane (ICRF-159).
Gilbert JM; Thompson EM; Slavin G; Kark AE
Br J Surg; 1984 Aug; 71(8):600-3. PubMed ID: 6743979
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy of chemically-induced colorectal tumours.
Gilbert JM; Thompson EM; Slavin G; Kark AE
J R Soc Med; 1983 Jun; 76(6):467-72. PubMed ID: 6864720
[TBL] [Abstract][Full Text] [Related]
3. Randomized trial of oral adjuvant razoxane (ICRF 159) in resectable colorectal cancer: five-year follow-up.
Gilbert JM; Hellmann K; Evans M; Cassell PG; Taylor RH; Stoodley B; Ellis H; Wastell C
Br J Surg; 1986 Jun; 73(6):446-50. PubMed ID: 3521784
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant oral razoxane (ICRF-159) in resectable colorectal cancer.
Gilbert JM; Hellmann K; Evans M; Cassell PG; Stoodley B; Ellis H; Wastell C
Cancer Chemother Pharmacol; 1982; 8(3):293-9. PubMed ID: 7127660
[TBL] [Abstract][Full Text] [Related]
5. Experimental colorectal cancer as a model of human disease.
Gilbert JM
Ann R Coll Surg Engl; 1987 Mar; 69(2):48-53. PubMed ID: 3566126
[TBL] [Abstract][Full Text] [Related]
6. Sulfasalazine alters the character of dimethylhydrazine-induced colorectal carcinoma in rats.
Andrianopoulos GD; Nelson RL; Barch DH; Nyhus LM
Anticancer Res; 1989; 9(6):1725-8. PubMed ID: 2576350
[TBL] [Abstract][Full Text] [Related]
7. A controlled prospective trial of adjuvant razoxane in resectable colorectal cancer.
Gilbert JM; Cassell PC; Ellis H; Wastell C; Hellmann K; Evans MG; Stoodley BJ
Recent Results Cancer Res; 1981; 79():48-58. PubMed ID: 7029684
[TBL] [Abstract][Full Text] [Related]
8. Eastern Cooperative Oncology Group phase II studies in advanced measurable colorectal cancer. I. Razoxane, Yoshi-864, piperazinedione, and lomustine.
Douglass HO; MacIntyre JM; Kaufman J; Von Hoff D; Engstrom PF; Klaassen D
Cancer Treat Rep; 1985 May; 69(5):543-5. PubMed ID: 2988774
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of ICRF-159 (NSC-129943) in advanced colorectal carcinoma.
Marciniak TA; Moertel CG; Schutt AJ; Hahn RG; Reitemeier RJ
Cancer Chemother Rep; 1975; 59(4):761-3. PubMed ID: 1100228
[No Abstract] [Full Text] [Related]
10. Adjuvant oral Razoxane (ICRF 159) in resectable colo-rectal cancer.
Slevin ML; Harvey VJ; Wrigley PF
Cancer Chemother Pharmacol; 1983; 10(3):228-9. PubMed ID: 6345019
[No Abstract] [Full Text] [Related]
11. Prospective serial liver ultrasound scanning in resectable colorectal cancer treated with adjuvant razoxane.
Taylor RH; Gilbert JM; Evans MG; Lane HG; Cassell PG
Clin Exp Metastasis; 1984; 2(4):321-31. PubMed ID: 6399698
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of ICRF-159 in patients with metastatic colorectal carcinoma previously exposed to systemic chemotherapy.
Bellet RE; Engstrom PF; Catalano RB; Creech RH; Mastrangelo MJ
Cancer Treat Rep; 1976 Sep; 60(9):1395-7. PubMed ID: 1016973
[No Abstract] [Full Text] [Related]
13. Effect of razoxane on metastases from colorectal cancer.
Hellmann K; Gilbert J; Evans M; Cassell P; Taylor R
Clin Exp Metastasis; 1987; 5(1):3-8. PubMed ID: 3829494
[TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy of advanced colorectal cancer with triazinate and ICRF-159 after failure of 5-Fluorouracil.
Vogl SE; Lanham R; Kaplan BH
Oncology; 1980; 37(5):314-5. PubMed ID: 7003455
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of dimethylhydrazine bowel carcinogenesis in rats.
Steele G; Crissey M; Gittes R; Harte P; Wilson R; Corson J
Cancer; 1981 May; 47(9):2218-21. PubMed ID: 7226115
[TBL] [Abstract][Full Text] [Related]
16. [Cocarcinogenic and promoting effects of choleretic cholagogues on large bowel carcinogenesis evoked by 1,2-dimethylhydrazine in Wistar rats].
Zhang WD
Zhonghua Bing Li Xue Za Zhi; 1988 Dec; 17(4):286-8. PubMed ID: 3254756
[No Abstract] [Full Text] [Related]
17. Razoxane, metastasis and adjuvant chemotherapy.
Hellmann K
Clin Exp Metastasis; 1987; 5(1):1-2. PubMed ID: 3829493
[No Abstract] [Full Text] [Related]
18. Combination chemotherapy for advanced colorectal cancer with triazinate, ICRF-159, 5-FU, and methyl-CCNU.
Vogl SE; Qazi R; Berenzweig M
Cancer Treat Rep; 1980; 64(10-11):1143-5. PubMed ID: 7459902
[TBL] [Abstract][Full Text] [Related]
19. An investigation into the mechanism of co-carcinogenesis of dietary cholesterol during the induction of colon cancer in rats by 1,2 dimethylhydrazine.
Cruse JP; Lewin MR; Clark CG
Clin Oncol; 1984 Sep; 10(3):213-20. PubMed ID: 6478681
[TBL] [Abstract][Full Text] [Related]
20. The effect of cholecystectomy on the induction of colorectal tumors in mice by 1,2-dimethylhydrazine.
Weitz H; Kirscheneder C; Wiebecke B; Eder M
Res Exp Med (Berl); 1984; 184(1):59-65. PubMed ID: 6729255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
